NAMPT and cancer: As a continuation to a previous study on the pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT) describing the metabolic basis of NAMPT inhibition [1], we report here the results of a global metabolomics analysis that revealed the metabolic alterations of NAMPT inhibition in human cancer cells.